Healthcare · Drug Manufacturers - Specialty & Generic
· website
$0.03
52wk 0.03 – 0.11
Overall
22.0
Value
72.7
Growth
0.0
Health
0.0
Quality
34.8
Momentum
0.0
Dividend
—
Price
About Argent BioPharma Limited
Argent BioPharma Limited, a clinical-stage biopharmaceutical company, develops nano-engineered therapeutics that reset the balance between the nervous and immune systems in Malta, Slovenia, Australia, and the United Kingdom. The company's principal product candidates include CimetrA, which is in phase III clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the relief of Dementia and Alzheimer's. It is also involved in the preclinical development of Irnicann for the treatment of Glioblastoma Multiforme; and R&D, which focuses on wound management. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
Price analytics
Returns
1 day
-6.3%
1 week
-6.3%
1 month
0.0%
3 months
-58.3%
6 months
-25.0%
1 year
-68.4%
3 years
-98.5%
Risk
Volatility (1y ann.)
144.3%
Beta vs ASX 200
0.41
Sharpe (1y)
-0.25
VaR 95% (1-day)
-10.6%
Max drawdown (1y)
-68.4%
Off 1-year high
-68.4%
Technicals
RSI(14)
44
vs 50DMA
-16.3%
vs 200DMA
-32.9%
Trend
Death cross
Fundamental trends
Financial statements
Loading…
Scoring breakdown
(2 Oct 2026)
Value72.7
Trailing P/E
—
Forward P/E
—
PEG ratio
—
EV / EBITDA
100
Price / Book
100
Price / Sales
0
Growth0.0
Revenue growth (1y)
0
Revenue CAGR (3y)
0
EPS growth (1y)
—
EPS CAGR (3y)
—
Financial Health0.0
Net debt / EBITDA
—
Interest coverage (EBIT/interest)
0
Current ratio
0
Debt / Equity
—
Quality (Profitability & Cash Flow)34.8
Return on equity
—
Return on assets
0
Operating margin
100
Net margin
0
Cash conversion (OCF / net income)
—
Dividend / Income—
No meaningful dividend — pillar excluded from the overall score.
Momentum0.0
6-month return vs ASX 200
0
Price vs 200-day average
0
Price vs 50-day average
0
Position in 52-week range
0
Hover a row's info icon for the exact rule. Bounds and weights are configurable in
the Django admin (Scoring configuration).